Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites

Atherosclerosis

Volumn 139, Issue 1, 1998, Pages 131-136

  Boright, Andrew P ^a   Connelly, Philip W ^a   Brunt, J Howard ^b   Scherer, Stephen W ^c   Tsui, Lap Chee ^c   Hegele, Robert A ^d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Alberta Hutterites; Genetic variation; Paraoxonase 1; Paraoxonase 2; Plasma lipoproteins; PON1; PON2

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B; ARYLESTERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CANADA; CHROMOSOME 7Q; DISEASE ASSOCIATION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0032127075     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00071-9     Document Type: Article

References (31)

1. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science. 265:1994;2037-2048.
2. Schork N.J. Genetically complex cardiovascular traits: origins, problems, and potential solutions. Hypertension. 29:1997;145-149.
3. Hegele R.A. The genetic basis of atherosclerosis. Int J Clin Lab Res. 27:1997;2-13.
4. Hegele R.A. Candidate genes, small effects, and the prediction of atherosclerosis. Crit Rev Clin Lab Sci. 34:1997;343-367.
5. Hegele R.A., Brunt J.H., Connelly P.W. A polymorphism of the angiotensinogen gene is associated with variation in blood pressure in a genetic isolate. Circulation. 90:1994;2207-2212.
6. Hegele R.A., Evans A.J., Tu L., Ip G., Brunt J.H., Connelly P.W. A gene-gender interaction affecting lipoproteins in a genetic isolate. Arterioscler Thromb. 14:1994;671-678.
7. Hegele R.A., Brunt J.H., Connelly P.W. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. Arterioscler Thromb Vasc Biol. 15:1995;89-95.
8. Hegele R.A., Brunt J.H., Connelly P.W. Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites. Arterioscler Thromb Vasc Biol. 15:1995;861-871.
9. Hegele R.A., Brunt J.H., Connelly P.W. Genetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation. 92:1995;1089-1093.
10. Hegele R.A., Breckenridge W.C., Brunt J.H., Connelly P.W. Genetic variation in factor VII associated with variation in plasma lipoprotein(a) concentration. Arterioscler Thromb Vasc Biol. 17:1997;1701-1706.
11. Hegele R.A., Brunt J.H., Connelly P.W. Genetic and biochemical factors associated with variation in blood pressure in a genetic isolate. Hypertension. 27:1996;308-312.
12. La Du B.N. Structural and functional diversity of paraoxonases. Nat Med. 2:1996;1186-1187.
13. Primo-Parmo S.L., Sorenson R.C., Telber J., La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 33:1996;498-507.
14. Mackness M.I., Mackness B., Durrington P.N., Connelly P.W., Hegele R.A. Paraxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol. 7:1996;69-76.
15. Ruiz J., Blanche H., James R.W., Blatter-Garin M.C., Vaisse C., Charpentier G., Cohen N., Morabia A., Passa P., Froguel P. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet. 346:1995;869-872.
16. Serrato M., Marian A.J. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest. 96:1995;3005-3008.
17. Odawara M., Tachi Y., Yamashita K. Paraoxonase polymorphism (Gln-Arg 192) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus. J Clin Endo Metab. 82:1997;2257-2260.
18. Sanghera D.K., Saha N., Aston C.E., Kamboh M.I. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol. 17:1997;1067-1073.
19. Antikainen M., Murtomaki S., Syvaine M., Pahlman R., Tahvanainen E., Jaunianen M. The Gln-Arg l9l Polymorphism of the paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest. 98:1996;883-885.
20. Herrmann S.M., Blanc H., Poirier O., Arveller D., Luc G., Evans A., Marques-Vidal P., Bard J.M., Cambien F. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study. Atherosclerosis. 126:1996;299-303.
21. Hegele R.A., Connelly P.W., Hanley A.J., Sun F., Harris S.B., Zinman B. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arterioscler Thromb Vasc Biol. 17:1997;1060-1066.
22. Hegele R.A., Connelly P.W., Scherer S.W., Hanley A.J., Harris S.B., Tsui L.C., Zinman B. Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes. Lancet. 350:1997;785.
23. Hegele R.A., Connelly P.W., Scherer S.W., Hanley A.J., Harris S.B., Tsui L.C., Zinman B. Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 82:1997;3373-3377.
24. Connelly P.W., Maclean D.R., Horlick L., O'Connor B., Petrasovits A., Little J.A. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Can Med Assoc J. 146:1992;1977-1987.
25. Mochizuki H. Scherer S, Nickle DC, Xi T, Majer M, Tsui LC, Bogardus C, Prochazka M. The human PON2 gene at 7q21.3: multiple RNA forms and missense polymorphisms in the coding sequence. Gene (submitted).
26. Hill W.G., Robertson A. Linkage disequilibrium in finite populations. Theor Appl Genet. 38:1968;226-231.
27. SAS Institute. SAS/STAT Guide for Personal Computers, version 6.12. Cary, NC:SAS Inc, 1995.
28. Blatter M.-C., James R.W., Messmer S., Barja F., Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein K-45. Eur J Biochem. 211:1993;871-879.
29. Saha N., Roy A.C., Teo S.H., Tay J.S.H., Ratnam S.S. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin Genet. 40:1991;277-282.
30. Mackness M.I., Harty D., Bhatnagar D., Winocour P.H., Arrol S., Ishola M., Durrington P.N. Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus. Atherosclerosis. 86:1991;193-199.
31. Pavkovic E., Simeon V., Reiner E., Sucic M., Lipovac V. Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders. Chem Biol-Interact. 87:1993;179-182.